chartexchange

SGMT
Sagimet Biosciences Inc. Series A Common Stock
stockNASDAQ

Market OpenNov 19, 2026 3:59:20 PM EST
9.61USD-4.896%(-0.50)753,347
Pre-marketNov 19, 2026 9:28:30 AM EST
10.00USD-1.088%(-0.11)
9.5800Bid9.6000Ask0.0200Spread

SGMT Financials

In Q3 FY 2026 (ended ), Sagimet Biosciences Inc. Series A Common Stock (SGMT) reported net income of −$19.15M, operating cash flow of −$12.11M, and assets of $282.09M (filed ).

Loading financial statements…